Purchases and Sales Made in Q4 2024 in C4 Therapeutics, Inc. (CCCC)
This table provides information about the institutional ownership of C4 Therapeutics, Inc. (CCCC) during Q4 2024. The information is specifically focused on institutions that hold shares of C4 Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 14, 2025
Q4 2024
|
Hennion & Walsh Asset Management, Inc.
|
BUY
|
- |
34.8K+ 18.08% |
$125K - $243K
|
227K
$850K
|
|
|
Jan 23, 2025
Q4 2024
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
BUY
|
- |
15KNew |
$53.9K - $105K
|
15K
$56K
|
|
|
Jan 22, 2025
Q4 2024
|
R Squared LTD
Central, K3 |
BUY
|
- |
3.31KNew |
$11.9K - $23.2K
|
3.31K
$12.4K
|
|
|
Jan 15, 2025
Q4 2024
|
Skopos Labs, Inc.
Riverhead, NY |
BUY
|
- |
3.03KNew |
$10.9K - $21.2K
|
3.03K
$11.3K
|